Table 1 Patient characteristics and management
n (%) or median (IQR) | All patients | Survivors | Non-survivors |
|---|---|---|---|
n = 725 | n = 631 (87.0) | n = 94 (13.0) | |
Age, years | 65.0 (53.0-77.0) | 64.0 (51.0-76.0) | 73.5 (63.8-83.0)* |
Age >65 | 351 (48.4) | 284 (45.0) | 67 (71.3)* |
Male sex | 338 (46.6) | 299 (47.4) | 39 (41.5) |
Comorbidity | |||
Cancer | 292 (40.3) | 247 (39.1) | 45 (47.9) |
Cardiopulmonary | 233 (32.1) | 189 (30.0) | 44 (46.8)* |
Immuno compromised | 198 (27.3) | 175 (27.7) | 23 (24.5) |
Neuropsychiatric | 177 (24.4) | 149 (23.6) | 28 (29.8) |
Diabetes mellitus | 134 (18.5) | 110 (17.4) | 24 (25.5) |
Renal disease | 96 (13.2) | 83 (13.2) | 13 (13.8) |
Liver disease | 22 (3.0) | 21 (3.3) | 1 (1.1) |
Suspected focus of infection | |||
Lower respiratory tract | 213 (29.4) | 179 (28.4) | 34 (36.2) |
Urinary tract | 152 (21.0) | 138 (21.9) | 14 (14.9) |
Gastrointestinal tract | 94 (13.0) | 82 (13.0) | 12 (12.8) |
Hepatobiliary system | 43 (5.9) | 37 (5.9) | 6 (6.4) |
Skin | 39 (5.4) | 34 (5.4) | 5 (5.3) |
Upper respiratory tract | 37 (5.1) | 36 (5.7) | 1 (1.1) |
Other | 147 (20.3) | 125 (19.8) | 22 (23.4) |
Antibiotics at ED | 647 (89.2) | 558 (88.4) | 89 (94.7) |
Disposition | |||
No admission | 63 (8.7) | 62 (9.8) | 1 (1.1)† |
Regular ward | 626 (86.3) | 544 (86.2) | 82 (87.2) |
MCU/ICU | 36 (5.0) | 25 (4.0) | 11 (11.7)‡ |
Length of hospital stay, days | 6 (3–11) | 7 (3–12) | 5 (2–10)‡ |
Severity scores | |||
AbbMEDS | 5 (2–8) | 3 (2–7) | 8 (6–11)* |
CURB-65 | 1 (0–2) | 1 (0–2) | 2 (1–3)* |